🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

OP-1250

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, in clinical trials for breast cancer.

Tags: ER antagonist, OP-1250, biopharmaceutical, breast cancer therapy, women's cancers

Website

About | Contact | Contact | Careers | Careers | About | About

Symbol: OLMA

Recent Price: $5.61

Industry: Biotechnology

CEO: Dr. Sean P. Bohen M.D., Ph.D.

Sector: Healthcare

Employees: 80

Address: 512 2nd Street, San Francisco, CA 94107

Phone: 650 243 5555

Last updated: 2024-12-31